New option listings for September 3rd include Oruka Therapeutics Inc (ORKA). Option delistings effective September 3rd include ARCA Biopharma (ABIO).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABIO:
- Oruka announces closing of merger with ARCA Biopharma
- ARCA Biopharma trading halted, news pending
- ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
- ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
- ARCA Biopharma updates on special dividend related to Oruka merger